Nu Skin Enterprises (NUS) Buy Rating and $75 PT Maintained at Pivotal Research

February 5, 2015 2:09 PM

Pivotal Research maintained a Buy rating on Nu Skin Enterprises (NYSE: NUS) with a price target of $75. Analyst Timothy ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found